论文部分内容阅读
目的观察布地奈德联合氨溴索雾化吸入治疗小儿急性支气管炎的疗效。方法将60例小儿急性支气管炎患儿随机分为治疗组和对照组各30例。对照组采用综合常规治疗。治疗组在常规治疗的基础上加布地奈德和氨溴索雾化吸入,对2组患儿临床疗效及不良反应发生情况进行比较。结果治疗组的总有效率为93.3%高于对照组的86.7%,差异有统计学意义(P<0.05)。治疗过程中2组均未出现严重不良反应。结论布地奈德联合氨溴索吸入治疗小儿急性支气管炎可明显改善症状,提高疗效。
Objective To observe the efficacy of budesonide combined with ambroxol inhalation in the treatment of children with acute bronchitis. Methods 60 cases of children with acute bronchitis were randomly divided into treatment group and control group of 30 cases. Control group using the conventional treatment. On the basis of routine treatment, the treatment group was given inhalation of budesonide and ambroxol, and compared the clinical efficacy and adverse reactions of the two groups. Results The total effective rate of the treatment group was 93.3%, which was significantly higher than that of the control group (86.7%, P <0.05). No significant adverse reactions occurred in both groups during the course of treatment. Conclusion Budesonide combined with ambroxol inhalation in children with acute bronchitis can significantly improve symptoms and improve efficacy.